• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性乳腺癌患者骨髓中孤立性乳腺癌细胞的检测

Detection of isolated mammary carcinoma cells in marrow of patients with primary breast cancer.

作者信息

Dearnaley D P, Ormerod M G, Sloane J P, Lumley H, Imrie S, Jones M, Coombes R C, Neville A M

出版信息

J R Soc Med. 1983 May;76(5):359-64. doi: 10.1177/014107688307600506.

DOI:10.1177/014107688307600506
PMID:6864701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1439138/
Abstract

Single cells from mammary carcinoma infiltrating bone marrow can be detected in marrow aspirates using immunocytochemical stains for epithelial membrane antigen (EMA). This technique has been used to examine marrow aspirates taken from multiple sites from 24 patients at surgery for breast cancer. Ten of these patients had EMA-positive cells in their marrow, while 32 marrow samples from patients who did not have carcinoma were negative. These results have been combined with those obtained by taking aspirates from single sites from 47 breast patients without known skeletal deposits. Follow up showed that the patients with EMA-positive cells in their marrow developed bone metastases at a significantly faster rate.

摘要

使用上皮膜抗原(EMA)免疫细胞化学染色法,可在骨髓穿刺物中检测到浸润骨髓的乳腺癌单细胞。该技术已用于检查24例乳腺癌手术患者多个部位的骨髓穿刺物。其中10例患者的骨髓中有EMA阳性细胞,而32例无癌患者的骨髓样本为阴性。这些结果与47例无已知骨骼转移的乳腺癌患者单部位穿刺物的结果相结合。随访显示,骨髓中含有EMA阳性细胞的患者发生骨转移的速度明显更快。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fb7/1439138/48cc6e5c19d5/jrsocmed00236-0033-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fb7/1439138/13b44703d1ea/jrsocmed00236-0031-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fb7/1439138/48cc6e5c19d5/jrsocmed00236-0033-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fb7/1439138/13b44703d1ea/jrsocmed00236-0031-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fb7/1439138/48cc6e5c19d5/jrsocmed00236-0033-a.jpg

相似文献

1
Detection of isolated mammary carcinoma cells in marrow of patients with primary breast cancer.原发性乳腺癌患者骨髓中孤立性乳腺癌细胞的检测
J R Soc Med. 1983 May;76(5):359-64. doi: 10.1177/014107688307600506.
2
Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen.使用抗上皮膜抗原抗血清增加骨髓涂片中乳腺癌细胞的检测。
Br J Cancer. 1981 Jul;44(1):85-90. doi: 10.1038/bjc.1981.152.
3
Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow.骨髓中播散性上皮肿瘤细胞免疫细胞化学筛查的方法学分析
J Hematother. 1994 Fall;3(3):165-73. doi: 10.1089/scd.1.1994.3.165.
4
Monoclonal antibody detection of carcinoma cells in bone marrow biopsy specimens from breast cancer patients.
Cancer. 1988 Jun 15;61(12):2407-11. doi: 10.1002/1097-0142(19880615)61:12<2407::aid-cncr2820611202>3.0.co;2-g.
5
Micrometastases in breast cancer: long-term follow-up of the first patient cohort.
Eur J Cancer. 1991;27(3):236-9. doi: 10.1016/0277-5379(91)90504-7.
6
The relationship between micrometastases in the bone marrow, histopathologic features of the primary tumor in breast cancer and prognosis.
Am J Clin Pathol. 1988 Jul;90(1):1-6. doi: 10.1093/ajcp/90.1.1.
7
Immunohistochemical staining of bone marrow biopsies for detection of occult metastasis in breast cancer.
Breast Cancer Res Treat. 1990 Jan;15(1):21-6. doi: 10.1007/BF01811886.
8
[Immunocytochemical detection of tumor cells in bone marrow as a prognostic factor in breast carcinoma].
Geburtshilfe Frauenheilkd. 1994 Dec;54(12):662-9. doi: 10.1055/s-2007-1022360.
9
The fate of bone marrow micrometastases in patients with primary breast cancer.
J Clin Oncol. 1989 Apr;7(4):445-9. doi: 10.1200/JCO.1989.7.4.445.
10
Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis.
J Clin Oncol. 1992 Oct;10(10):1534-9. doi: 10.1200/JCO.1992.10.10.1534.

引用本文的文献

1
Bone marrow micrometastases in early breast cancer-30-year outcome.早期乳腺癌中的骨髓微转移——30年随访结果
Br J Cancer. 2016 Feb 2;114(3):243-7. doi: 10.1038/bjc.2015.447. Epub 2016 Jan 14.
2
Expression of human milk fat globulin proteins in cells of haemopoietic origin.人乳脂肪球蛋白在造血起源细胞中的表达
Br J Cancer. 2000 Oct;83(7):874-9. doi: 10.1054/bjoc.2000.1404.
3
Epithelial membrane antigen: partial purification, assay and properties.上皮膜抗原:部分纯化、测定及性质

本文引用的文献

1
Physical test for distant metastases in patients with breast cancer.乳腺癌患者远处转移的体格检查
J R Soc Med. 1980 Sep;73(9):617-23. doi: 10.1177/014107688007300904.
2
A prognostic index in primary breast cancer.原发性乳腺癌的预后指数
Br J Cancer. 1982 Mar;45(3):361-6. doi: 10.1038/bjc.1982.62.
3
Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen.使用抗上皮膜抗原抗血清增加骨髓涂片中乳腺癌细胞的检测。
Br J Cancer. 1983 Oct;48(4):533-41. doi: 10.1038/bjc.1983.226.
4
The detection and evaluation of human tumor metastases.人类肿瘤转移的检测与评估。
Cancer Metastasis Rev. 1983;2(4):351-74. doi: 10.1007/BF00048567.
5
Immunocytochemistry in the identification of vascular invasion in breast cancer.免疫细胞化学在乳腺癌血管侵犯识别中的应用
J Clin Pathol. 1984 Apr;37(4):364-6. doi: 10.1136/jcp.37.4.364.
6
Twenty-sixth annual general meeting of the British Association for Cancer Research (in conjunction with the European Organization for Research and Treatment for Cancer--Pharmacokinetics and Metabolism Group and the Drug Metabolism Group). March 24-27, 1985, Birmingham, U.K.英国癌症研究协会第26届年会(与欧洲癌症研究与治疗组织——药代动力学与代谢小组及药物代谢小组联合举办)。1985年3月24日至27日,英国伯明翰
Br J Cancer. 1985 Sep;52(3):409-67. doi: 10.1038/bjc.1985.210.
7
A new monoclonal antibody to epithelial membrane antigen (EMA)-E29. A comparison of its immunocytochemical reactivity with polyclonal anti-EMA antibodies and with another monoclonal antibody, HMFG-2.一种针对上皮膜抗原(EMA)的新型单克隆抗体——E29。其免疫细胞化学反应性与多克隆抗EMA抗体及另一种单克隆抗体HMFG-2的比较。
Br J Cancer. 1985 Sep;52(3):355-61. doi: 10.1038/bjc.1985.201.
8
Production of monoclonal antibodies against human epithelial membrane antigen for use in diagnostic immunocytochemistry.用于诊断免疫细胞化学的抗人上皮膜抗原单克隆抗体的制备。
Br J Cancer. 1985 Sep;52(3):347-54. doi: 10.1038/bjc.1985.200.
9
Cross reactivity of anti-epithelial membrane antigen monoclonal for reactive and neoplastic glial cells.抗上皮膜抗原单克隆抗体对反应性和肿瘤性神经胶质细胞的交叉反应性。
J Neurooncol. 1987;4(4):345-52. doi: 10.1007/BF00195605.
10
The value of bone marrow examination for tumor staging in breast cancer.骨髓检查在乳腺癌肿瘤分期中的价值。
J Cancer Res Clin Oncol. 1988;114(4):425-8. doi: 10.1007/BF02128190.
Br J Cancer. 1981 Jul;44(1):85-90. doi: 10.1038/bjc.1981.152.
4
The use of antisera to epithelial membrane antigen in detecting micrometastases in histological sections.使用抗上皮膜抗原抗血清检测组织切片中的微转移灶。
Br J Cancer. 1980 Sep;42(3):392-8. doi: 10.1038/bjc.1980.250.
5
Monoclonal antibodies to the human mammary gland. I. Distribution of determinants in non-neoplastic mammary and extra mammary tissues.针对人类乳腺的单克隆抗体。I. 非肿瘤性乳腺及乳腺外组织中决定簇的分布
Virchows Arch A Pathol Anat Histol. 1982;394(3):279-93. doi: 10.1007/BF00430671.
6
Distribution of epithelial membrane antigen in normal and neoplastic tissues and it value in diagnostic tumor pathology.上皮膜抗原在正常组织和肿瘤组织中的分布及其在肿瘤诊断病理学中的价值。
Cancer. 1981 Apr 1;47(7):1786-95. doi: 10.1002/1097-0142(19810401)47:7<1786::aid-cncr2820470711>3.0.co;2-8.
7
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.需要对每位患者进行长期观察的随机临床试验的设计与分析。II. 分析与示例。
Br J Cancer. 1977 Jan;35(1):1-39. doi: 10.1038/bjc.1977.1.
8
A new antigen on the epithelial membrane: its immunoperoxidase localisation in normal and neoplastic tissue.上皮细胞膜上的一种新抗原:其免疫过氧化物酶在正常组织和肿瘤组织中的定位
J Clin Pathol. 1979 Jan;32(1):35-9. doi: 10.1136/jcp.32.1.35.